HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Relapses after withdrawal of proguanil treatment in tropical splenomegaly syndrome.

Abstract
After the remission of symptoms and reduction in spleen size while on proguanil therapy four patients with the tropical splenomegaly syndrome defaulted from treatment. The withdrawal of proguanil caused a recrudescence of original symptoms, splenomegaly, and a return of the initially raised serum IgM. Complete return to normal values was again effected with proguanil therapy.The role of the spleen in the tropical splenomegaly syndrome in the production of the raised serum IgM is discussed. These patients should be educated as to the nature of their disease and the importance of continued medical treatment.
AuthorsA S David-West
JournalBritish medical journal (Br Med J) Vol. 3 Issue 5929 Pg. 499-501 (Aug 24 1974) ISSN: 0007-1447 [Print] England
PMID4415529 (Publication Type: Journal Article)
Chemical References
  • Immunoglobulin A
  • Immunoglobulin G
  • Immunoglobulin M
  • Proguanil
Topics
  • Adult
  • Anthropometry
  • Female
  • Humans
  • Hypergammaglobulinemia (complications)
  • Immunoglobulin A (analysis)
  • Immunoglobulin G (analysis)
  • Immunoglobulin M (analysis)
  • Liver (pathology)
  • Lymphocyte Activation
  • Lymphocytosis
  • Malaria (drug therapy)
  • Middle Aged
  • Prognosis
  • Proguanil (therapeutic use)
  • Recurrence
  • Spleen (pathology)
  • Splenomegaly (complications, diagnosis, drug therapy, pathology)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: